Announced Wed, 9 Sept, 2026 · 12:56 IST
NSE seeks clarification on quarterly results compliance
Regulatory & LegalExplain this filing
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹152.02
prior close
₹152.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+0.3-2.6-2.7-4.0-2.1-1.0-9.4———
Up moveDown movePending
AI summary
NSE has asked Nath Bio-Genes to clarify certain aspects of its financial results for the quarter ended 30-Jun-2026 under SEBI LODR Regulation 33. The company's response is awaited. This is a routine exchange query, not a penalty or enforcement action.
Likely market impact
Routine procedural query; no immediate impact on stock or shareholders unless material issues surface in the response.